258 results on '"Kwong, Bernice Y."'
Search Results
2. Multi-center retrospective review of vitiligo-like lesions in breast cancer patients treated with cyclin-dependent kinase 4 and 6 inhibitors
3. Erythema dyschromicum perstans-like eruptions induced by epidermal growth factor receptor inhibitors in patients with lung cancer
4. Clinical features of drug-induced hypersensitivity syndrome to BRAF inhibitors with and without previous immune checkpoint inhibition: a review
5. Dermatologic Events Associated with the Anti-CCR4 Antibody Mogamulizumab: Characterization and Management
6. Incidence of Nonkeratinocyte Skin Cancer After Breast Cancer Radiation Therapy
7. Use of teledermatology by dermatology hospitalists is effective in the diagnosis and management of inpatient disease
8. Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Multicenter Retrospective Study of 377 Adult Patients from the United States
9. Improved Dermatologist, Patient, and Oncologist Collaboration Needed During Cancer Drug Development.
10. Cutaneous Adverse Events of Targeted Therapies for Hematolymphoid Malignancies
11. Sclerotic Eruptions
12. Evolution of a Project to Improve Inpatient-to-Outpatient Dermatology Care Transitions: Mixed Methods Evaluation
13. Development of a Framework for Addressing Skin Biopsy Tray Waste in Dermatology Clinics
14. Radiation Therapy for Primary Cutaneous Gamma Delta Lymphoma Prior to Stem Cell Transplantation
15. Association of Intraoperative Antibiotic Irrigation With Systemic Contact Dermatitis
16. Consensus on the clinical management of chronic radiation dermatitis and radiation fibrosis: a Delphi survey
17. Evolution of a project to improve inpatient-to-outpatient dermatology care transitions: a mixed methods evaluation (Preprint)
18. Nutritional deficiency contributing to refractory erythroderma in hematopoietic cell transplant patients: Distinctive clinical and histopathologic findings
19. Expert consensus recommendations for managing hyperglycemia and rash in patients with PIK3CA-mutated, hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) advanced breast cancer (ABC) treated with alpelisib (ALP).
20. Histologic subtype of cutaneous immune-related adverse events predicts overall survival in patients receiving immune checkpoint inhibitors
21. Ibrutinib‐associated rash: a single‐centre experience of clinicopathological features and management
22. Immunotherapy for keratinocyte cancers. Part II: Identification and management of cutaneous side effects of immunotherapy treatments.
23. Cutaneous Complications of Targeted Melanoma Therapy
24. Teledermatology to Facilitate Patient Care Transitions From Inpatient to Outpatient Dermatology: Mixed Methods Evaluation
25. Acanthosis nigricans in the setting of severe pulmonary disease exacerbated by COVID-19 infection
26. Effect of voriconazole on risk of nonmelanoma skin cancer after hematopoietic cell transplantation
27. Limited Role of Random Skin Biopsy in the Diagnosis of Intravascular Lymphoma in Adult Patients with Hemophagocytic Lymphohistiocytosis
28. Management of Dermatologic Complications of Lung Cancer Therapies
29. Langerhans Cells Facilitate Epithelial DNA Damage and Squamous Cell Carcinoma
30. Teledermatology to Facilitate Patient Care Transitions from Inpatient to Outpatient Dermatology: a Mixed Methods Evaluation (Preprint)
31. A 10-year retrospective cohort study of ruxolitinib and association with nonmelanoma skin cancer in patients with polycythemia vera and myelofibrosis
32. Clinicopathologic characterization of enfortumab vedotin-associated cutaneous toxicity in patients with urothelial carcinoma
33. Immunohistochemical analysis of lichenoid reactions in patients treated with anti-PD-L1 and anti-PD-1 therapy
34. Acral verruca-like presentation of chronic graft-vs.-host disease
35. Dermatologic Events Associated with the Anti-CCR4 Antibody Mogamulizumab: Characterization and Management
36. Cutaneous Reactive Angiomatosis associated with Intravascular Cryoprotein Deposition as the Presenting Finding in a Patient with Underlying Lymphoplasmacytic Lymphoma: A Case Report and Review of the Literature
37. Histopathologic correlation of skin manifestations of multisystem inflammatory syndrome in adults associated with SARS-CoV-2 infection
38. Dermatologic toxicities of targeted antineoplastic agents and immune checkpoint inhibitor therapy in pediatric patients: A systematic review
39. Clinical features of drug-induced hypersensitivity syndrome to BRAF inhibitors with and without previous immune checkpoint inhibition: a review
40. Corrigendum to “Anti-Cancer Therapy Related Hand-Foot Syndrome in Patients with Systemic Sclerosis: Case Series and Literature Review” [Current Problems in Cancer: Case Reports 1C (2020)]
41. Pruritus as a Paraneoplastic Symptom of Thymoma
42. Complete remission from intralesional talimogene laherparepvec for regionally advanced Merkel cell carcinoma in an immunocompromised solid organ transplant patient
43. Drug-induced hypersensitivity syndrome like reaction with angioedema and hypotension associated with BRAF inhibitor use and antecedent immune checkpoint therapy
44. Clinical Characterization of Mogamulizumab-Associated Rash During Treatment of Mycosis Fungoides or Sézary Syndrome
45. Using Visual Arts Education in Dermatology to Benefit Resident Wellness and Clinical Communication
46. Erratum to: Cutaneous Complications of Targeted Melanoma Therapy
47. Anti-cancer therapy related hand-foot syndrome in patients with systemic sclerosis: Case series and literature review
48. Disseminated non-Langerhans cell histiocytosis with an IRF2BP2-NTRK1 gene fusion identified by next-generation sequencing
49. Outcomes of Embedding Dermatologic Care Within Oncology Practices for Patients With Cancer
50. Histopathologic Characterization of Mogamulizumab-associated Rash
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.